Table 2 Bleeding and Thromboembolic events
Endpoints events | the UFH group (n = 109) | INR a | the UFH-LMWH group (n = 99) | INR | the LMWH group (n = 97) | INR |
|---|---|---|---|---|---|---|
Bleeding events | 3 (2.3%) | 2.67 | 5 (6.3%) | 2.69 | 10 (10.3%) | 2.77 |
Epistaxis | 1 (0.8%) | 2.21 | 3 (3.8%) | 2.31 | 7 (7.3%) | 2.42 |
Airway bleeding | 0 (0) | – | 1 (1.3%) | 4.05b | 1 (1.0%) | 3.85b |
Hematuria | 1 (0.8%) | 2.38 | 0 (0) | – | 1 (1.0%) | 2.55 |
Hematemesis | 0 (0) | – | 1 (1.3%) | 2.46 | 0 (0) | – |
Gastrointestinal bleeding | 1 (0.8%) | 3.42b | 0 (0) | – | 1 (1.0%) | 4.37b |
Thromboembolic events | 2 (1.6%) | 1.96 | 0 (0) | – | 0 (0) | – |
Permanent stroke | 1 (0.8%) | 1.77 | 0 (0) | – | 0 (0) | – |
Transient stroke | 1 (0.8%) | 2.15 | 0 (0) | – | 0 (0) | – |